微信公众号
News Center
Industry News
2022-05-18
According to GLOBOCAN 2020 global cancer statistics, in 2020, the incidence of renal cell carcinoma ranked 14th among malignant tumors worldwide, lower than prostate cancer and bladder cancer of the urinary system, and the mortality rate ranked 15th. Recently, the "Guidelines for the Diagnosis and Treatment of Renal Cell Carcinoma (2022 Edition)" were released. This article summarizes parts of the etiology and clinical manifestations of renal cell carcinoma.
Learn More Details
2022-04-25
On April 23-24, 2022, the CSCO Guidelines Conference was held as scheduled. Regardless of changes in the external environment, the Chinese Society of Clinical Oncology (CSCO) has never stopped advancing the industry and improving the standardized diagnosis and treatment of tumors in China. This guidelines conference covered updates and insightful interpretations of guidelines for major tumor types. In addition, multiple guidelines were issued in areas such as tumor metastasis and adverse reactions to tumor treatments, providing a basis for clinical work and standardized diagnosis and treatment.
Learn More Details